Does metabolic syndrome influence short and long term durability of carotid endarterectomy and stenting?
<br/><strong>Aims: </strong>The metabolic syndrome (MetS) is composed of a cluster of related cardiovascular risk factors. The aim of the present study was to determine how MetS contributes to short‐ (30‐day) and long‐term complications and restenosis after carotid endarterectomy (...
Principais autores: | Casana, R, Malloggi, C, Tolva, V, Odero, A, Bulbulia, R, Halliday, A, Silani, V |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Wiley
2018
|
Registros relacionados
-
Is diabetes a marker of higher risk after carotid revascularization? Experience from a single centre
por: Casana, R, et al.
Publicado em: (2018) -
Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the asymptomatic carotid surgery trial-2
por: Huibers, A, et al.
Publicado em: (2015) -
Ocular defects as surrogate end-points in trials comparing carotid endarterectomy and stenting.
por: Giannoukas, A, et al.
Publicado em: (2014) -
The Asymptomatic Carotid Surgery Trial-2 (ACST-2): An ongoing randomised trial comparing carotid endarterectomy with carotid artery stenting to prevent stroke
por: Bulbulia, R, et al.
Publicado em: (2017) -
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time
por: Lokuge, K, et al.
Publicado em: (2017)